The joint pain injections market size is poised to grow by $ 7.59 billion by 2030 from $ 4.43 Billion in 2022, exhibiting a CAGR of 6.9% during the forecast period 2022 to 2030.
The main objective of this report is to define, describe, and forecast the global market by types, application, manufacturers, and regions. The report provides detailed information about the major factors (drivers, restraints, opportunities, and industry-specific challenges) influencing the growth of the market. The report aims to strategically analyze the micro markets with respect to individual growth trends, prospects, and contributions to the global market. The report also attempts to forecast the market size of the 5 main regions: North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA), and Latin America. It strategically profiles the key market players and comprehensively analyzes their core competencies. It also tracks and analyzes competitive developments, such as joint ventures, mergers and acquisitions, new developments, and Research and Development (R&D) activities, in market.
Get a Sample: https://www.precedenceresearch.com/sample/1449
COVID-19 Impact
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the electric vehicle fuel cell market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Major companies operating in this are
- Anika Therapeutics Inc.
- Bioventus
- Ferring Pharmaceuticals Inc.
- Sanofi
- Zimmer Biomet Holdings Inc.
- Allergen Plc.
- Pfizer Inc.
- Chugai Pharmaceutical Co. Ltd
- SEIKAGAKU Corporation
- Ferring B.V.
Market Segmentation
By Injection Type
- Corticosteroid Injections
- Hyaluronic Acid Injections
- Platelet-rich Plasma Injections
- Placental tissue matrix (PTM) Injections
By Joint Type
- Knee and Ankle
- Hip
- Shoulder and Elbow
- Spinal Joints
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Product Type
- Pre-filled injections
- Vials
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Latin America
- MEA
- Rest of the World
Major highlights of Report:
- Figures related to sales volume, market remuneration, and segmental shares
- Featuring market dynamics
- Growth prospects and expansion graph
- PROCON study of direct & indirect sales channels
- Profiles of prominent traders, dealer, and distributors in the industry
Geographical landscape: North America, Europe, Asia-Pacific, South America, Middle East and Africa
- Industry forecasts based on region and at country level
- Data about sales volume recorded, industry share held, and profit margins amassed
- Overall remuneration and estimated growth rate for each regional market
Major Key Points Covered in Report:
Executive Summary: It includes key trends of the electric vehicle fuel cell market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the electric vehicle fuel cell market based on production and revenue.
Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.
Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Electric vehicle fuel cell market.
Market Segments: This part of the report discusses product, application and other segments of the electric vehicle fuel cell market based on market share, CAGR, market size, and various other factors.
Research Methodology: This section discusses the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Joint Pain Injections Market
5.1. COVID-19 Landscape: Joint Pain Injections Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Joint Pain Injections Market, By Product
8.1. Joint Pain Injections Market, by Product Type, 2021-2030
8.1.1. Pre-filled injections
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Vials
8.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Joint Pain Injections Market, By Injection
9.1. Joint Pain Injections Market, by Injection, 2021-2030
9.1.1. Corticosteroid Injections
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Hyaluronic Acid Injections
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Platelet-rich Plasma Injections
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Placental tissue matrix (PTM) Injections
9.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Joint Pain Injections Market, By Joint Type
10.1. Joint Pain Injections Market, by Joint Type, 2021-2030
10.1.1. Knee and Ankle
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Hip
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Shoulder and Elbow
10.1.3.1. Market Revenue and Forecast (2019-2030)
10.1.4. Spinal Joints
10.1.4.1. Market Revenue and Forecast (2019-2030)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Joint Pain Injections Market, By Distribution Type
11.1. Joint Pain Injections Market, by Distribution Type, 2021-2030
11.1.1. Hospital Pharmacies
11.1.1.1. Market Revenue and Forecast (2019-2030)
11.1.2. Retail Pharmacies
11.1.2.1. Market Revenue and Forecast (2019-2030)
11.1.3. Online Pharmacies
11.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 12. Global Joint Pain Injections Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.2. Market Revenue and Forecast, by Injection (2019-2030)
12.1.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.1.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.5.2. Market Revenue and Forecast, by Injection (2019-2030)
12.1.5.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.1.5.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.6.2. Market Revenue and Forecast, by Injection (2019-2030)
12.1.6.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.1.6.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.2. Market Revenue and Forecast, by Injection (2019-2030)
12.2.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.2.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.5.2. Market Revenue and Forecast, by Injection (2019-2030)
12.2.5.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.2.5.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.6.2. Market Revenue and Forecast, by Injection (2019-2030)
12.2.6.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.2.6.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.7.2. Market Revenue and Forecast, by Injection (2019-2030)
12.2.7.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.2.7.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.8.2. Market Revenue and Forecast, by Injection (2019-2030)
12.2.8.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.2.8.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.2. Market Revenue and Forecast, by Injection (2019-2030)
12.3.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.3.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.5.2. Market Revenue and Forecast, by Injection (2019-2030)
12.3.5.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.3.5.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.6.2. Market Revenue and Forecast, by Injection (2019-2030)
12.3.6.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.3.6.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.7.2. Market Revenue and Forecast, by Injection (2019-2030)
12.3.7.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.3.7.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.8.2. Market Revenue and Forecast, by Injection (2019-2030)
12.3.8.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.3.8.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.2. Market Revenue and Forecast, by Injection (2019-2030)
12.4.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.4.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.5.2. Market Revenue and Forecast, by Injection (2019-2030)
12.4.5.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.4.5.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.6.2. Market Revenue and Forecast, by Injection (2019-2030)
12.4.6.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.4.6.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.7.2. Market Revenue and Forecast, by Injection (2019-2030)
12.4.7.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.4.7.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.8.2. Market Revenue and Forecast, by Injection (2019-2030)
12.4.8.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.4.8.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.2. Market Revenue and Forecast, by Injection (2019-2030)
12.5.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.5.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.5.2. Market Revenue and Forecast, by Injection (2019-2030)
12.5.5.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.5.5.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.6.2. Market Revenue and Forecast, by Injection (2019-2030)
12.5.6.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.5.6.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
Chapter 13. Company Profiles
13.1. Online Pharmacies
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Bioventus
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Ferring Pharmaceuticals Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Sanofi
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Zimmer Biomet Holdings Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Allergen Plc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Pfizer Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Chugai Pharmaceutical Co. Ltd
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. SEIKAGAKU Corporation
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Ferring B.V.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments